Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lina Jimena Cortés"'
Autor:
Juan Hormazábal, Loreto Nuñez-Franz, Paola Rubilar, Mauricio Apablaza, Cecilia Vial, Lina Jimena Cortés, Natalia González, Pablo Vial, Macarena Said, Claudia González, Kathya Olivares, Ximena Aguilera, Muriel Ramírez-Santana
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100372- (2023)
Objective: The study compared immunity to the original SARS-CoV-2 virus (Wuhan) and the Omicron variant using neutralizing antibodies (NAbs), that provide a good approximation of protective immunity. The results might help determine immunization stra
Externí odkaz:
https://doaj.org/article/ea7528395f634e6fb13e28b9d2e42c20
Autor:
Maria Cecilia Poli, Cecilia Vial, Emma Rey-Jurado, Natalia González, Lina Jimena Cortés, Juan Hormazabal, Carolina Ramírez-Riffo, Javiera de la Cruz, Camilo Ulloa
Publikováno v:
Vaccines, Vol 11, Iss 5, p 1012 (2023)
Chronic kidney disease (CKD) patients have an increased risk of morbidity and mortality following SARS-CoV-2 infection. Vaccination in these patients is prioritized, and monitoring of the immune response is paramount to define further vaccination str
Externí odkaz:
https://doaj.org/article/2f9e9c367ede42e9a9928e40a1ac26ba
Autor:
Loreto Núñez-Franz, Muriel Ramírez-Santana, Paola Rubilar, Cecilia Vial, Mauricio Apablaza, Claudia González, Macarena Said, Kathya Olivares, Lina Jimena Cortés, Juan Hormazábal, Luis Canales, Pablo Vial, Gloria Icaza, Rubén Quezada-Gaete, Ximena Aguilera
Publikováno v:
Viruses, Vol 15, Iss 1, p 201 (2023)
Background: Chile has achieved the highest coverage for vaccines against the SARS-CoV-2 virus worldwide. Objective: To assess the progression of immunity (natural and acquired by vaccine) in a cohort from two Chilean cities. Methods: Individuals (n =
Externí odkaz:
https://doaj.org/article/1607ff752aa24e119705ca9850db81ec
Autor:
Nubia F. Barrera, Luz M. Melgarejo, Maribel Cruz-Gallego, Lina Jimena Cortés, Fanny Guzmán, Julio C. Calvo
Publikováno v:
Molecules, Vol 23, Iss 9, p 2262 (2018)
The rice hoja blanca virus (RHBV), transmitted by the planthopper insect Tagosodes orizicolus, is a disease that attacks rice and generates significant production losses in Colombia. Fedearroz 2000 and Colombia I commercial rice varieties, which have
Externí odkaz:
https://doaj.org/article/87f801ddf06946318c67a979800592d3
Autor:
Emma Rey-Jurado, Yazmin Espinosa, Camila Astudillo, Lina Jimena Cortés, Juan Hormazabal, Loreani P. Noguera, Fernanda Cofré, Cecilia Piñera, Ricardo González, Alexander Bataszew, Paula Muñoz Venturelli, Dona Benadof, Patricia Álvarez, Valeria Acevedo, Pablo Vial, Cecilia Vial, M. Cecilia Poli
Publikováno v:
Journal of Allergy and Clinical Immunology. 150:1074-1085.e11
Multisystemic inflammatory syndrome in children (MIS-C) is a life-threatening disease that occurs 2-5 weeks after severe acute respiratory syndrome coronavirus 2 exposure and is characterized by severe multisystemic inflammation. Early recognition of
Autor:
Luz Marina Melgarejo, Lina Jimena Cortés, Fanny Guzmán, Maribel Cruz-Gallego, Julio C Calvo, Nubia F. Barrera
Publikováno v:
Molecules, Vol 23, Iss 9, p 2262 (2018)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules
Volume 23
Issue 9
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules
Volume 23
Issue 9
The rice hoja blanca virus (RHBV), transmitted by the planthopper insect Tagosodes orizicolus, is a disease that attacks rice and generates significant production losses in Colombia. Fedearroz 2000 and Colombia I commercial rice varieties, which have
Autor:
Gabriela Meza-Fuentes, René López, Cecilia Vial, Lina Jimena Cortes, Mauricio A. Retamal, Iris Delgado, Pablo Vial
Publikováno v:
Viruses, Vol 15, Iss 10, p 1995 (2023)
Hantavirus cardiopulmonary syndrome (HCPS) is a severe respiratory illness primarily associated with microvascular endothelial changes, particularly in the lungs. However, the role of the pulmonary epithelium in HCPS pathogenesis remains unclear. Thi
Externí odkaz:
https://doaj.org/article/1b1f4846cc5d4c2abcca0900dd6e1ca0
Autor:
Alejandro Escobar, Felipe E. Reyes-López, Mónica L. Acevedo, Luis Alonso-Palomares, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Hugo Portillo, Jimena Gatica, Ivan Flores, Estefanía Nova-Lamperti, Carlos Barrera-Avalos, María Rosa Bono, Leonardo Vargas, Valeska Simon, Elias Leiva-Salcedo, Cecilia Vial, Juan Hormazabal, Lina Jimena Cortes, Daniel Valdés, Ana M. Sandino, Mónica Imarai, Claudio Acuña-Castillo
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
CoronaVac vaccine from Sinovac Life Science is currently being used in several countries. In Chile, the effectiveness of preventing hospitalization is higher than 80% with a vaccination schedule. However, to date, there are no data about immune respo
Externí odkaz:
https://doaj.org/article/567bda70ec194d8aa689dad8556c9e4f
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
Autor:
Ximena Aguilera, Juan Hormazábal, Cecilia Vial, Lina Jimena Cortes, Claudia González, Paola Rubilar, Mauricio Apablaza, Muriel Ramírez-Santana, Gloria Icaza, Loreto Nuñez-Franz, Carla Castillo-Laborde, Carolina Ramírez-Riffo, Claudia Pérez, Rubén Quezada-Gate, Macarena Said, Pablo Vial
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1051 (2022)
Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters. From a population-based study performed in November 2021, we rand
Externí odkaz:
https://doaj.org/article/33b72fb474b040a3a2fa241a2a1226f0
Autor:
Ximena Aguilera, Claudia González, Mauricio Apablaza, Paola Rubilar, Gloria Icaza, Muriel Ramírez-Santana, Claudia Pérez, Lina Jimena Cortes, Loreto Núñez-Franz, Rubén Quezada-Gaete, Carla Castillo-Laborde, Juan Correa, Macarena Said, Juan Hormazábal, Cecilia Vial, Pablo Vial
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1002 (2022)
Chile is among the most successful nations worldwide in terms of its COVID-19 vaccine rollout. By 31 December 2021, 84.1% of the population was fully vaccinated, and 56.1% received booster doses using different COVID-19 vaccines. In this context, we
Externí odkaz:
https://doaj.org/article/af01ab779dd84578ac11fd680fd14ab4